Abstract
No public abstract is available from the verified source records.
Rima D Patel, Joseph A. Sparano
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
openalex
Confidence 95%
unpaywall
Confidence 95%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Cancer statistics for African American and Black people, 2025
10.3322/caac.21874 · 2025
Cancer statistics, 2026
2026
The contribution of race to breast tumor microenvironment composition and disease progression
10.3389/fonc.2020.01022 · 2020
Deconstructing racial and ethnic disparities in breast cancer
10.1001/jamaoncol.2020.7113 · 2021
Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group
10.1093/jnci/djp175 · 2009
Racial disparity in distant recurrence-free survival in patients with localized breast cancer: a pooled analysis of National Surgical Adjuvant Breast and Bowel Project trials
10.1002/cncr.34241 · 2022
Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial
10.1093/jnci/djr543 · 2012
Impact of genetic ancestry on outcomes in ECOG-ACRIN-E5103
10.1200/po.17.00059 · 2017
Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer
10.1056/nejmoa1804710 · 2018
21-gene assay to inform chemotherapy benefit in node-positive breast cancer
datacite
Confidence 0%
10.1056/nejmoa2108873 · 2021
Use of biomarkers to guide decisions on adjuvant systemic therapy for women with early-stage invasive breast cancer: ASCO clinical practice guideline update-integration of results from TAILORx
10.1200/jco.19.00945 · 2019
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
10.1016/j.annonc.2023.11.016 · 2024
NCCN Guidelines® insights: breast cancer, version 5.2025
10.6004/jnccn.2025.0053 · 2025
Molecular drivers of oncotype DX, Prosigna, EndoPredict, and the breast cancer index: a TransATAC Study
10.1200/jco.20.00853 · 2021
Association of race/ethnicity and the 21-gene recurrence score with breast cancer-specific mortality among US women
10.1001/jamaoncol.2020.7320 · 2021
Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial
10.1093/jnci/djae314 · 2025
Recurrence Score® gene group components and outcomes in the RxPONDER trial (SWOG S1007)
10.1093/jnci/djag221 · 2026
Relationship between topoisomerase 2A RNA expression and recurrence after adjuvant chemotherapy for breast cancer
10.1158/1078-0432.ccr-09-1450 · 2009
Race, ethnicity, and clinical outcomes in hormone receptor-positive, HER2-negative, node-negative breast cancer in the randomized TAILORx trial
10.1093/jnci/djaa148 · 2021
Impact of race/ethnicity on MammaPrint genomic assay risk and prognosis in early breast cancer: a National Cancer Data Base analysis
10.1002/cncr.35771 · 2025
Abstract P2-10-08: racial disparities in breast cancer: identifying predisposing clinical and molecular features associated with African American patients
10.1158/1538-7445.sabcs19-p2-10-08 · 2020
No additional external references are available.